Two Sigma Investments’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-4,500
Closed -$677K 4267
2021
Q4
$677K Sell
4,500
-1,900
-30% -$256K ﹤0.01% 2935
2021
Q3
$764K Sell
6,400
-12,600
-66% -$1.39M ﹤0.01% 2873
2021
Q2
$1.85M Buy
19,000
+9,200
+94% +$820K ﹤0.01% 1936
2021
Q1
$865K Sell
9,800
-34,600
-78% -$3.22M ﹤0.01% 2454
2020
Q4
$4.25M Buy
44,400
+10,400
+31% +$1.07M 0.01% 1027
2020
Q3
$3.86M Buy
34,000
+10,600
+45% +$1.11M 0.01% 930
2020
Q2
$2.31M Sell
23,400
-11,900
-34% -$950K 0.01% 1024
2020
Q1
$2.27M Buy
35,300
+22,900
+185% +$1.6M 0.02% 900
2019
Q4
$739K Sell
12,400
-6,000
-33% -$370K ﹤0.01% 2472
2019
Q3
$1.08M Buy
18,400
+9,800
+114% +$626K ﹤0.01% 1920
2019
Q2
$555K Buy
+8,600
New +$555K ﹤0.01% 2414
2019
Q1
Sell
-22,100
Closed -$839K 3473
2018
Q4
$839K Buy
+22,100
New +$780K ﹤0.01% 1761

Other funds holding TNDM

Two Sigma Investments's TNDM Position: Q1 2026 in Review

Two Sigma Investments increased its Tandem Diabetes Care (TNDM) stake by 55% in Q1 2026, buying an estimated $14.4M and bringing the position to 1,864,194 shares worth $35.7M. The position accounts for 0.03% of the portfolio, ranked #645.

Two Sigma Investments first reported a position in TNDM in Q1 2014 and has held it in 29 quarters since. The position peaked at $56.7M in Q1 2019. 272 funds tracked by Wall St. Rank hold TNDM as of Q1 2026.

  • Two Sigma Investments held 1,864,194 shares of Tandem Diabetes Care worth $35.7M as of Q1 2026.
  • Two Sigma Investments bought 662,667 Tandem Diabetes Care shares in Q1 2026, an estimated $14.4M.
  • Tandem Diabetes Care made up 0.03% of Two Sigma Investments's portfolio in Q1 2026, its #645 holding.
  • Two Sigma Investments first reported a position in Tandem Diabetes Care in Q1 2014 and has held it in 29 quarters since.
  • Two Sigma Investments's Tandem Diabetes Care position peaked at $56.7M in Q1 2019.
  • 272 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.